Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 118,300 | 163,700 | 121,000 | 81,200 | 89,900 |
| Marketable Securities | 42,100 | 54,100 | 60,500 | 60,400 | 52,700 |
| Receivables | 87,100 | 71,000 | 105,000 | 121,800 | 121,800 |
| Inventories | 26,600 | 29,100 | 30,800 | 28,100 | 28,100 |
| Other current assets | 0 | 0 | 0 | 32,900 | 0 |
| TOTAL | $394,500 | $331,700 | $355,200 | $365,300 | $329,500 |
| Non-Current Assets | |||||
| PPE Net | 36,700 | 37,000 | 37,100 | 36,500 | 55,000 |
| Investments And Advances | 30,200 | 37,000 | 42,800 | 47,600 | 51,500 |
| Intangibles | 919,200 | 932,900 | 947,100 | 1,061,600 | 1,083,900 |
| Other Non-Current Assets | 63,900 | 66,000 | 64,500 | 67,300 | 71,300 |
| TOTAL | $1,050,000 | $1,072,900 | $1,091,500 | $1,213,000 | $1,261,700 |
| Total Assets | $1,444,500 | $1,404,600 | $1,446,700 | $1,578,300 | $1,591,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,100 | 21,700 | 30,300 | 21,000 | 24,000 |
| Accrued Expenses | 65,400 | 75,900 | 63,100 | 61,100 | 73,000 |
| Other current liabilities | 3,300 | 3,100 | N/A | 13,900 | 3,300 |
| TOTAL | $133,700 | $147,000 | $113,200 | $112,400 | $115,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 224,600 | 224,400 | 225,200 | 225,100 | 225,000 |
| Deferred Revenues | 32,300 | 32,800 | 3,800 | 3,600 | 2,100 |
| Other Non-Current Liabilities | 101,600 | 88,500 | 81,800 | 88,000 | 99,400 |
| TOTAL | $401,500 | $339,400 | $366,300 | $388,600 | $401,300 |
| Total Liabilities | $535,200 | $486,400 | $479,500 | $501,000 | $516,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,210 | N/A | 74,555 | 74,550 | 74,389 |
| Common Shares | 800 | 700 | 700 | 700 | 700 |
| Retained earnings | -189,100 | -173,900 | -118,500 | -3,300 | 5,000 |
| Other shareholders' equity | -3,600 | -5,200 | -7,800 | -5,200 | -7,500 |
| TOTAL | $909,300 | $918,200 | $967,200 | $1,077,300 | $1,074,500 |
| Total Liabilities And Equity | $1,444,500 | $1,404,600 | $1,446,700 | $1,578,300 | $1,591,200 |